Better

Million

<ul class="list-ic vertical"> 
 <li> <span>1</span> <a>AMPH stock price continued to rise since May after a long phase of consolidation.&nbsp;</a> </li> 
 <li> <span>2</span> <a>Amphastar Pharmaceuticals earnings constantly pushed the stock price in the past.&nbsp;</a> </li> 
</ul> 
<p>Amphastar Pharmaceuticals (NASDAQ: AMPH) stock price is trading at its all time high price since its listing. The small cap company within the pharmaceutical space is among the leading ones within the space. The mid-cap companies become a preferable choice if they bring considerable return, which is a no brainer.&nbsp;</p> 
<p>The broader medical sector lost 0.57% value in the last intraday session when Amphastar stock price gained up to 1.50%. Tech-heavy NASDAQ dropped 2% in the similar time frame and the S&amp;P 500 Pharmaceuticals Industry Index was 3% down.&nbsp;</p> 
<h1 class="wp-block-heading" id="strong-amphastar-pharmaceuticals-500m-deal-with-lilly-strong"><strong>Amphastar Pharmaceuticals $500M Deal With Lilly</strong></h1> 
<p>In April, the company came into an agreement with a giant player in the <a href="https://www.thecoinrepublic.com/2023/07/14/recursion-pharmaceuticals-receives-50m-rxrx-stock-shoots-80/" target="_blank" rel="noopener noreferrer nofollow">pharma</a> sector, Eli Lilly and Co (NYSE: ELI). Amphastar was reported to acquire Baqsimi nasal spray from Lilly in a deal worth $500 Million cash and additional $125 Million to be paid within a year of the deal.&nbsp;</p> 
<p>Though the deal was significantly big for Amphastar given the company’s small-cap size, it decided to go all in with the available cash and senior credit facility. The deal to acquire the nasally administered product, which generated $139.3 Million in revenue last year, did not bring enthusiasm to the investors and the AMPH stock price had to suffer.&nbsp;</p> 
<h2 class="wp-block-heading" id="strong-ever-getting-better-earnings-for-amphastar-pharmaceuticals-strong"><strong>Ever Getting Better Earnings for Amphastar Pharmaceuticals</strong></h2> 
<p>Amphastar Pharmaceuticals reported a revenue of $140.02 Million, 2% more than the estimated revenue of $137.2 Million. The company reported earnings per share (EPS) of $0.62, 16% up from the expected EPS of $0.53.&nbsp;</p> 
<p>The company had been doing well in terms of revenue and EPS for the past several years. In the longer time frame, AMPH stock price increased over 250% in the last five years while the company turned profitable in the recent three years. For this latter part, on an average Amphastar EPS grew by 20% and revenue by 16% annually every year.</p> 
<h3 class="wp-block-heading" id="strong-amphastar-pharmaceuticals-amph-stock-price-movement-strong"><strong>Amphastar Pharmaceuticals (AMPH) Stock Price Movement</strong></h3> 
<p>AMPH stock has been moving up since the last earnings report of the first quarter of 2023 in May. The stock price of the drug maker company has been trading in an uptrend since then. It has gained nearly 75% of its value within less than three months.&nbsp;</p> 
<p>Prior to the support from above $35, Amphastar share price was in a downtrend during April. Following the announcement of a deal with Lilly to acquire Baqsini, AMPH stock price fell up to 6% in a day and over 18% in the coming 4 days. However, the better than estimated earnings acted as damage control.&nbsp;</p> 
<div class="wp-block-image"> 
 <figure class="aligncenter size-large is-resized"> 
  <img decoding="async" loading="lazy" src="https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-1024x460.png" alt="Amphastar Pharmaceuticals Hits ATH at $63; Uptrend to Continue?" class="wp-image-153256" width="1200" height="539" srcset="https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-1024x460.png 1024w, https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-300x135.png 300w, https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-768x345.png 768w, https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-1536x689.png 1536w, https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-750x337.png 750w, https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163-1140x512.png 1140w, https://www.thecoinrepublic.com/wp-content/uploads/2023/07/image-163.png 1600w" sizes="(max-width: 1200px) 100vw, 1200px"> 
  <figcaption class="wp-element-caption">
    &nbsp;source : Amphastar Pharmaceuticals (NASDAQ: AMPH) Stock Price Movement on <a href="https://www.tradingview.com/x/pb5neOnz/" target="_blank" rel="noopener noreferrer nofollow">TradingView</a> 
  </figcaption> 
 </figure> 
</div> 
<p>Currently, the AMPH stock price is above the 50- and 200-day EMA and the gap between both the exponential moving-averages is ever broadening. MACD is above the zero-line and signifies a crossover, suggesting a bullish move ahead. RSI is at 68 indicating the stock is about to enter the overbought zone, so a slight retracement could be expected.&nbsp;</p> 
<h5 class="wp-block-heading"><strong>Disclaimer</strong></h5> 
<p>The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.</p>

Amphastar Pharmaceuticals Hits ATH at $63; Uptrend to Continue?

Table of Contents

Thecoinrepublic.com

Other articles published on Jul 21, 2023

Shiba Inu Price Prediction: Is the SHIB Price Undervalued?

MKR Shows Enormous 20% Increase, This Is What Caused It

Cardano (ADA) Price Prediction: Uwerx (WERX) Token Presale Coming to an End

Bitcoin Mining Uses Landfill Methane Gas for Eco-Friendly Electricity

Will XRP Reach $1 This Month?

IBM Stock – Price Hikes After Mixed Quarterly Earning Report

Join our free newsletter for daily crypto updates!